BioSpace News Archive

Building on over ten years of experience in the cell culture and isolation of cell products, KromaTiD is excited to announce the launch of a comprehensive suite of Cell and Blood Culture growth, isolation, processing, and quality control services.

Clover Biopharmaceuticals, Ltd., a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, announced the appointment of Nicholas Jackson, Ph.D., as President of Global Research and Development.

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced today that it has completed the acquisition of Virex Health, Inc., a Boston, MA based company (“Virex”), spun out of the labs of Professors Mark Grinstaff and Scott Schaus at BU, on February 1, 2022.

Clarity Pharmaceuticals (ASX: CU6) (“Clarity”), a clinical-stage radiopharmaceutical company developing next-generation products to address the growing needs in oncology, is pleased to announce that it has completed cohort 1 and advanced to cohort 2 in the 64Cu/67Cu SARTATE™ Neuroblastoma trial (CL04 trial).

Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company and Aspen, a South African headquartered multinational pharmaceutical company announced today their partnership to launch Trelstar® (Triptorelin) in South Africa for the treatment of locally advanced and metastatic hormone dependent prostate cancer.

NTx, a bioinformatics and biomanufacturing company advancing cell free, continuous flow manufacturing solutions for medical products and material sciences, today announced that the company has received a grant from the Bill & Melinda Gates Foundation to advance novel solutions for mRNA production and related supply chain challenges.

Synaptogenix, Inc. (Nasdaq: SNPX) (“the Company”), today announced that its peer-reviewed scientific manuscript entitled, “Bryostatin Placebo-Controlled Trials Indicate Cognitive Restoration Above Baseline for Advanced Alzheimer’s Disease (“AD”) in the Absence of Memantine” was published in the Journal of Alzheimer’s Disease.

The global professional services firm ZS announced today that it has entered into a strategic partnership through a supporting multimillion dollar investment in IgniteData, a U.K.-based digital health startup shaping the future of clinical research through its Archer technology.

Partnership between Temedica, a leading digital health and health insights company, and NOVENTI Health SE, the largest provider of enterprise resource planning (ERP) systems and claims management solutions for pharmacies in Germany

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present three abstracts featuring new data on oral, once-daily ORLADEYO® (berotralstat) for the prophylactic treatment of hereditary angioedema (HAE) at the 2022 American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting.